174 related articles for article (PubMed ID: 26512636)
1. Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit.
Wu C; Wang M; Tang Q; Luo R; Chen L; Zheng P; Zhu W
Molecules; 2015 Oct; 20(10):19361-71. PubMed ID: 26512636
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Biological Evaluation and Docking Studies of Sorafenib Derivatives N-(3-fluoro-4-(pyridin-4-yloxy)phenyl)-4(5)-phenylpicolinamides.
Wang M; Wu C; Xu S; Zhu Y; Li W; Zheng P; Zhu W
Med Chem; 2017; 13(2):176-185. PubMed ID: 27855595
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit.
Wang M; Xu S; Wu C; Liu X; Tao H; Huang Y; Liu Y; Zheng P; Zhu W
Bioorg Med Chem Lett; 2016 Nov; 26(22):5450-5454. PubMed ID: 27777009
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, activity and docking studies of phenylpyrimidine-carboxamide Sorafenib derivatives.
Wang W; Wu C; Wang J; Luo R; Wang C; Liu X; Li J; Zhu W; Zheng P
Bioorg Med Chem; 2016 Dec; 24(23):6166-6173. PubMed ID: 28340913
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antitumor activity of Novel Sorafenib derivatives bearing pyrazole scaffold.
Wang M; Xu S; Lei H; Wang C; Xiao Z; Jia S; Zhi J; Zheng P; Zhu W
Bioorg Med Chem; 2017 Oct; 25(20):5754-5763. PubMed ID: 28927801
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitumor activities of novel benzyl urea analogues of sorafenib.
Lu CS; Tang K; Li Y; Jin B; Yin DL; Ma C; Chen XG; Huang HH
Yao Xue Xue Bao; 2013 May; 48(5):709-17. PubMed ID: 23888694
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
9. [Design, synthesis and antitumor activity of sorafenib analogues containing 2-picolinylhydrazide moiety].
Qin AF; Li Y; Song HR; Chen XG; Jin XF; Wang K; Zhang LJ; Huo LC; Feng ZQ
Yao Xue Xue Bao; 2012 Dec; 47(12):1623-9. PubMed ID: 23460968
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and in vitro cytotoxic activities of sorafenib derivatives].
Wang K; Li Y; Zhang LJ; Yang HZ; Chen XG; Feng ZQ
Yao Xue Xue Bao; 2014 May; 49(5):639-43. PubMed ID: 25151734
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis.
El-Miligy MM; Abd El Razik HA; Abu-Serie MM
Future Med Chem; 2017 Oct; 9(15):1709-1729. PubMed ID: 28925739
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and biological evaluation of sorafenib thiourea derivatives].
Yang Z; Fang Z; Wang ZX; Wei P
Yao Xue Xue Bao; 2011 Sep; 46(9):1093-7. PubMed ID: 22121780
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel pyrazolo-oxothiazolidine derivatives as antiproliferative agents against human lung cancer cell line A549.
Yakaiah S; Sagar Vijay Kumar P; Baby Rani P; Durga Prasad K; Aparna P
Bioorg Med Chem Lett; 2018 Feb; 28(4):630-636. PubMed ID: 29395969
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of diaryl urea derivatives designed as potential anticarcinoma agents using de novo structure-based lead optimization approach.
Azimian F; Hamzeh-Mivehroud M; Shahbazi Mojarrad J; Hemmati S; Dastmalchi S
Eur J Med Chem; 2020 Sep; 201():112461. PubMed ID: 32663641
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf.
Chen KF; Tai WT; Huang JW; Hsu CY; Chen WL; Cheng AL; Chen PJ; Shiau CW
Eur J Med Chem; 2011 Jul; 46(7):2845-51. PubMed ID: 21531053
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Biological Evaluation of a New Series of 1-Aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea Derivatives as Antiproliferative Agents.
Zhang C; Tan X; Feng J; Ding N; Li Y; Jin Z; Meng Q; Liu X; Hu C
Molecules; 2019 Jun; 24(11):. PubMed ID: 31167363
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents.
Roaiah HM; Ghannam IAY; Ali IH; El Kerdawy AM; Ali MM; Abbas SE; El-Nakkady SS
Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29323750
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a Nanomolar Multikinase Inhibitor (KST016366): A New Benzothiazole Derivative with Remarkable Broad-Spectrum Antiproliferative Activity.
El-Damasy AK; Cho NC; Nam G; Pae AN; Keum G
ChemMedChem; 2016 Aug; 11(15):1587-95. PubMed ID: 27405013
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors.
Tu Y; OuYang Y; Xu S; Zhu Y; Li G; Sun C; Zheng P; Zhu W
Bioorg Med Chem; 2016 Apr; 24(7):1495-503. PubMed ID: 26906472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
